TY - JOUR A1 - Müller-Nordhorn, J. A1 - Englert, Heike A1 - Wegscheider, K. A1 - Berger, H. A1 - Sonntag, F. A1 - Völler, H. A1 - Meyer-Sabellek, W. A1 - Reinhold, T. A1 - Windler, E. A1 - Katus, HA. A1 - Willich, SN. T1 - Productivity loss as a major component of disease-related costs in patients with hypercholesterolemia in Germany JF - Clin Res Cardiol Y1 - 2008 SN - 1861-0692 VL - 97 SP - 152-9 EP - - ER - TY - JOUR A1 - Müller-Nordhorn, J. A1 - Englert, Heike A1 - Wegscheider, K. A1 - Berger, H. A1 - Sonntag, F. A1 - Völler, H. A1 - Meyer-Sabellek, W. A1 - Windler, E. A1 - Katus, H. A1 - Willich, S. T1 - Is patient self-report an adequate tool for monitoring cardiovascular conditions in patients with hypercholesterolemia? – Results of the ORBITAL Study JF - J Public Health (Oxf) Y1 - 2010 SN - 1741-3850 VL - 32 IS - 3 SP - 387 EP - 394 ER - TY - JOUR A1 - Müller-Nordhorn, J. A1 - Englert, Heike A1 - Wegscheider, K. A1 - Berger, H. A1 - Sonntag, F. A1 - Völler, H. A1 - Meyer-Sabellek, W. A1 - Reinhold, T. A1 - Windler, E. A1 - Katus, HA. A1 - Willich, SN. T1 - Effect of an adherence-enhancing program on health-related quality of life in patients with hypercholesterolemia JF - Eur J Integrative Med Y1 - 2008 SN - 1876-3820 VL - 1 IS - 1 SP - 24 EP - - ER - TY - JOUR A1 - Müller-Nordhorn, J. A1 - Englert, Heike A1 - Sonntag, F. A1 - Völler, H. A1 - Windler, E. A1 - Meyer-Sabellek, W. A1 - Katus, H. A1 - Wegscheider, K. A1 - Willich, SN. T1 - Disease-related costs in patients with hypercholesterolemia JF - J Epi Community Health Y1 - 2004 SN - 0143-005X VL - 58 (Suppl.) SP - 20 EP - - ER - TY - JOUR A1 - Willich, SN. A1 - Müller-Nordhorn, J. A1 - Englert, Heike A1 - Sonntag, F. A1 - Völler, H. A1 - Meyer-Sabellek, W. A1 - Wegscheider, K. A1 - Windler, E. A1 - Katus, H. T1 - Cost-of-illness analysis in patients with hypercholesterolemia JF - Circulation Y1 - 2005 SN - 2574-8300 VL - 111 SP - 342 EP - 343 ER - TY - JOUR A1 - Willich, SN A1 - Müller-Nordhorn, J. A1 - Englert, Heike A1 - Upmeier, H. A1 - Meyer-Sabellek, W. A1 - Wegscheider, K. T1 - Disease-related costs in patients with hypercholesterolaemia JF - Eur Heart J Y1 - 2003 SN - 0195-668X VL - 24 SP - 586 EP - - ER - TY - JOUR A1 - Willich, S. N. A1 - Englert, Heike A1 - Sonntag, F. A1 - Völler, H. A1 - Meyer-Sabellek, W. A1 - Wegscheider, K. A1 - Windler, E. A1 - Katus, H. A. A1 - Müller-Nordhorn, J. T1 - Impact of a compliance program on cholesterol control: results of the randomized ORBITAL study in 8108 patients treated with rosuvastatin JF - Eur J Cardiovasc Prev Rehabil N2 - Abstract This study extends previous research evaluating the association between the CHIP intervention, change in body weight, and change in psychological health. A randomized controlled health intervention study lasting 4 wk. was used with 348 participants from metropolitan Rockford, Illinois; ages ranged from 24 to 81 yr. Participants were assessed at baseline, 6 wk., and 6 mo. The Beck Depression Inventory (BDI) and three selected psychosocial measures from the SF-36 Health Survey were used. Significantly greater decreases in Body Mass Index (BMI) occurred after 6 wk. and 6 mo. follow-up for the intervention group compared with the control group, with greater decreases for participants in the overweight and obese categories. Significantly greater improvements were observed in BDI scores, role-emotional and social functioning, and mental health throughout follow-up for the intervention group. The greater the decrease in BMI through 6 wk., the better the chance of improved BDI score, role-emotional score, social functioning score, and mental health score, with odds ratios of 1.3 to 1.9. Similar results occurred through 6 mo., except the mental health variable became nonsignificant. These results indicate that the CHIP intervention significantly improved psychological health for at least six months afterwards, in part through its influence on lowering BMI. Y1 - 2009 VL - 16 SP - 180 EP - 187 ER -